Xponance, Inc. Biogen Inc. Transaction History

Xponance, Inc.

$9.68 Billion
Q2 2024

A detailed history of Xponance, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Xponance, Inc. holds 21,081 shares of BIIB stock, worth $3.66 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

21,081

Previous 21,036 0.21%

Holding current value

$3.66 Million

Previous $4.54 Million 7.74%

% of portfolio

0.05%

Previous 0.05%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $8,573 - $10,652	45 Added 0.21%	21,081 $4.89 Million
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $209,687 - $264,765	989 Added 4.93%	21,036 $4.54 Million
Q4 2023 Jan 31, 2024	SELL	$222.59 - $267.94 $277,347 - $333,853	-1,246 Reduced 5.85%	20,047 $5.19 Million
Q3 2023 Oct 23, 2023	BUY	$253.3 - $285.89 $366,271 - $413,396	1,446 Added 7.29%	21,293 $5.47 Million
Q2 2023 Jul 13, 2023	BUY	$275.25 - $318.06 $18,441 - $21,310	67 Added 0.34%	19,847 $5.65 Million
Q1 2023 Apr 17, 2023	BUY	$256.56 - $292.34 $127,510 - $145,292	497 Added 2.58%	19,780 $5.5 Million
Q4 2022 Jan 23, 2023	BUY	$252.44 - $306.72 $1.06 Million - $1.28 Million	4,183 Added 27.7%	19,283 $0
Q3 2022 Oct 24, 2022	BUY	$194.69 - $268.46 $500,353 - $689,942	2,570 Added 20.51%	15,100 $4.03 Million
Q2 2022 Aug 02, 2022	BUY	$187.54 - $223.02 $513,672 - $610,851	2,739 Added 27.97%	12,530 $2.56 Million
Q1 2022 Apr 20, 2022	BUY	$193.77 - $244.14 $70,532 - $88,866	364 Added 3.86%	9,791 $2.06 Million
Q4 2021 Jan 31, 2022	BUY	$223.92 - $287.77 $424,104 - $545,036	1,894 Added 25.14%	9,427 $2.26 Million
Q3 2021 Nov 05, 2021	SELL	$282.99 - $369.05 $229,221 - $298,930	-810 Reduced 9.71%	7,533 $2.13 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $764,827 - $1.22 Million	-2,953 Reduced 26.14%	8,343 $2.89 Million
Q1 2021 May 10, 2021	SELL	$242.95 - $284.63 $55,635 - $65,180	-229 Reduced 1.99%	11,296 $3.16 Million
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $2.26 Million - $3.39 Million	-9,545 Reduced 45.3%	11,525 $2.82 Million
Q3 2020 Oct 26, 2020	SELL	$264.77 - $305.71 $672,251 - $776,197	-2,539 Reduced 10.75%	21,070 $5.98 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $6.11 Million - $8.09 Million	23,609 New	23,609 $6.32 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account